Starwood Capital Group - Company Review
Starwood Capital Group - Company ReviewSummary
Starwood Capital Group (SCG) is an investment firm that invests in real estate such as multifamily, hotel, office, retail, industrial, residential and commercial land, senior housing, mixed-use, golf and asset classes such as equity, preferred equity, mezzanine debt and senior debt. The firm also invests in private transactions, public offerings, privatizations and responsible investing. Its funds include starwood global opportunity fund x (sof x); starwood distressed opportunity fund ix (sof ix); starwood global opportunity fund viii (sof viii); and others. The firm also has presence in Greenwich, Atlanta, Chicago, London, Luxembourg, Miami, Paris, San Francisco, Los Angeles, Frankfurt, Sao Paulo and Washington. SCG is headquartered in Greenwich, Connecticut, the US.
This comprehensive company report of Starwood Capital Group provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.